UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000020459
Receipt number R000023638
Scientific Title Study of the effects of anti-oxidant supplementation on fatigability in healthy elderly
Date of disclosure of the study information 2016/01/06
Last modified on 2017/07/14 10:44:37

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study of the effects of anti-oxidant supplementation on fatigability in healthy elderly

Acronym

Effects of anti-oxidant supplementation

Scientific Title

Study of the effects of anti-oxidant supplementation on fatigability in healthy elderly

Scientific Title:Acronym

Effects of anti-oxidant supplementation

Region

Japan


Condition

Condition

fatigability,Sarcopenia

Classification by specialty

Rehabilitation medicine

Classification by malignancy

Others

Genomic information

YES


Objectives

Narrative objectives1

To study efficacy of anti-oxidant supplementation on fatigability in healthy elderly.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

walking distance for 6-minutes
hemodynamics
oxidative stress

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

anti-oxidant supplementation, 3-month, 2 times per day

Interventions/Control_2

placebo, 3-month, 2 times per day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

subjects who can walk

Key exclusion criteria

1)Subjects who have previous medical history of drug and/or food allergy.
2)Subjects who have previous medical history and/or current medical history of serious diseases (e.g., diabetes, digestive organ, liver, pancreas, heart and/or kidney).
3)Subjects who have been enrolled in the other clinical trials within about last 1 month.
4)Subjects who predicted gluttony and irregular eating habits by the pre-questionnaire and doctor's questions.
5)Subjects who constantly use supplements and/or functional foods affecting fatigability.
6)Subjects who take medicines and plan to take new health foods.
7)Others who have been determined ineligible by principal investigator or sub-investigator.

Target sample size

80


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hidemi Fujino

Organization

Kobe University graduate School of Health Sciences

Division name

Rehabilitation Science

Zip code


Address

7-10-2 Tomogaoka, Kobe

TEL

078-796-4542

Email

fujino@phoenix.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Hidemi Fujino

Organization

Kobe University graduate School of Health Sciences

Division name

Rehabilitation Science

Zip code


Address

7-10-2 Tomogaoka, Kobe

TEL

078-796-4542

Homepage URL


Email

fujino@phoenix.kobe-u.ac.jp


Sponsor or person

Institute

Kobe University graduate School of Health Sciences

Institute

Department

Personal name



Funding Source

Organization

Kobe University graduate School of Health Sciences

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 01 Month 06 Day

Date of IRB


Anticipated trial start date

2016 Year 01 Month 06 Day

Last follow-up date

2017 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 01 Month 06 Day

Last modified on

2017 Year 07 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023638